LAP3 and chronic obstructive pulmonary disease: In mammals, their activity is tightly regulated by naturally occurring peptidase activators or inhibitors, such as serpins, and the disruption of the peptidase-inhibitor balance can lead to the dysregulation of inflammatory responses, as is observed in chronic obstructive pulmonary disease (24, –26) and acute experimental arthritis (27).